CRAZX | FLMAX | CRAZX / FLMAX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 12 years | 8 years | - |
Gain YTD | 8.389 | 18.694 | 45% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 2000 | 2500 | 80% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 2.52B | 956M | 264% |
Annual Yield % from dividends | 0.52 | 1.72 | 30% |
Returns for 1 year | 14.94 | 24.14 | 62% |
Returns for 3 years | -12.44 | 13.55 | -92% |
Returns for 5 years | 1.39 | 44.86 | 3% |
Returns for 10 years | 16.89 | N/A | - |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
INDS | 38.51 | 0.14 | +0.36% |
Pacer Benchmark Industrial RE SCTR ETF | |||
PBTP | 25.42 | 0.03 | +0.10% |
Invesco 0-5 Yr US TIPS ETF | |||
LMBS | 48.64 | -0.03 | -0.06% |
First Trust Low Duration Oppos ETF | |||
PPH | 86.59 | -1.58 | -1.79% |
VanEck Pharmaceutical ETF | |||
HELX | 28.55 | -1.41 | -4.72% |
Franklin Genomic Advancements ETF |